Author

Robert C Bast Jr

MD Anderson Cancer Center - Cited by 93,825 - Cell growth regulation of ovarian and breast carcinomas - Imprinted tumor suppressor genes - Autophagy and tumor dormancy - Early d

Biography

Robert C Bast is working in the Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, USA. Robert C Bast international experience includes various programs, contributions and participation in different countries for diverse fields of study. Robert C Bast research interests reflect wide range of publications in various national and international journals.
Title
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...autophagy 17 (1), 1-382, 202112199202
12199
2021
Biomarkers and strategies for early detection of ovarian cancer
RC Bast Jr, Z Lu, CY Han, KH Lu, KS Anderson, CW Drescher, SJ SkatesCancer Epidemiology, Biomarkers & Prevention 29 (12), 2504-2512, 2020202
55
2020
SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters
T Lyu, Y Jiang, N Jia, X Che, Q Li, Y Yu, K Hua, RC Bast Jr, W FengInternational journal of cancer 146 (6), 1553-1567, 2020202
30
2020
Targeting progesterone signaling prevents metastatic ovarian cancer
O Kim, EY Park, SY Kwon, S Shin, RE Emerson, YH Shin, FJ DeMayo, ...Proceedings of the National Academy of Sciences 117 (50), 31993-32004, 2020202
29
2020
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
O Kim, EY Park, DL Klinkebiel, SD Pack, YH Shin, Z Abdullaev, ...PLoS genetics 16 (6), e1008808, 2020202
28
2020
Directed evolution of cyclic peptides for inhibition of autophagy
JP Gray, MN Uddin, R Chaudhari, MN Sutton, H Yang, P Rask, H Locke, ...Chemical Science 12 (10), 3526-3543, 202
21
2021
IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming
N Niu, J Yao, RC Bast, AK Sood, J LiuOncogenesis 10 (9), 65, 202
21
2021
Multi-marker longitudinal algorithms incorporating HE4 and CA125 in ovarian cancer screening of postmenopausal women
A Gentry-Maharaj, O Blyuss, A Ryan, M Burnell, C Karpinskyj, R Gunu, ...Cancers 12 (7), 1931, 2020202
16
2020
Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders
YC Li, NK Lytle, ST Gammon, L Wang, TK Hayes, MN Sutton, RC Bast Jr, ...Proceedings of the National Academy of Sciences 117 (22), 12121-120, 2020202
13
2020
DIRAS3: an imprinted tumor suppressor gene that regulates RAS and PI3K-driven cancer growth, motility, autophagy, and tumor dormancy
G Bildik, X Liang, MN Sutton, RC Bast Jr, Z LuMolecular cancer therapeutics 21 (1), 25-37, 2022202
12
2022
Next steps in the early detection of ovarian cancer
RC Bast, CY Han, Z Lu, KH LuCommunications medicine 1 (1), 36, 2021202
12
2021
Circulating cancer biomarkers
A Lokshin, RC Bast, K RodlandCancers 13 (4), 802, 2021202
12
2021
Expression of B7–H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas
N Niu, W Shen, Y Zhong, RC Bast Jr, A Jazaeri, AK Sood, J LiuHuman pathology 3, 20-27, 2021202
11
2021
A MYC-driven plasma polyamine signature for early detection of ovarian cancer
JF Fahrmann, E Irajizad, M Kobayashi, J Vykoukal, JB Dennison, ...Cancers 13 (4), 913, 2021202
10
2021
Proteome profiling uncovers an autoimmune response signature that reflects ovarian cancer pathogenesis
M Kobayashi, H Katayama, E Irajizad, JV Vykoukal, JF Fahrmann, ...Cancers 12 (2), 485, 2020202
10
2020
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
Z Lu, W Mao, H Yang, JM Santiago-O’Farrill, PJ Rask, J Mondal, H Chen, ...The Journal of Clinical Investigation 132 (11), 2022202
8
2022
A novel salt inducible kinase 2 inhibitor, ARN-3261, sensitizes ovarian cancer cell lines and xenografts to carboplatin
D Fan, H Yang, W Mao, PJ Rask, L Pang, C Xu, H Vankayalapat, ...Cancers 13 (3), 446, 2021202
8
2021
Structure-based design of stapled peptides that bind GABARAP and inhibit autophagy
H Brown, M Chung, A Üffing, N Batistatou, T Tsang, S Doskocil, W Mao, ...Journal of the American Chemical Society 144 (32), 1468-1469, 2022202
7
2022
SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK
X Shi, X Yu, J Wang, S Bian, Q Li, F Fu, X Zou, L Zhang, RC Bast Jr, Z Lu, ...Molecular oncology 16 (13), 2558-254, 2022202
7
2022
Nuclear HKII-P-p53 (Ser15) interaction is a prognostic biomarker for Chemoresponsiveness and glycolytic regulation in epithelial ovarian Cancer
Nuclear HKII-P-p3 (Ser1) interaction is a prognostic biomarker for Chemoresponsiveness and glycolytic regulation in epithelial ovarian CancerCY Han, DA Patten, SI Kim, JJ Lim, DW Chan, MKY Siu, Y Han, ...Cancers 13 (14), 3399, 2021202
5
2021

Referred From: https://scholar.google.co.in/citations?user=JoZNkNQAAAAJ&hl=en

Cited by
Citations 93825
h-index 140
i10-index 555
Recommended Journals
Open Access Journals